vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and SOUTHSIDE BANCSHARES INC (SBSI). Click either name above to swap in a different company.
SOUTHSIDE BANCSHARES INC is the larger business by last-quarter revenue ($62.8M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). SOUTHSIDE BANCSHARES INC runs the higher net margin — 33.4% vs -19.9%, a 53.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -4.8%). SOUTHSIDE BANCSHARES INC produced more free cash flow last quarter ($73.5M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -0.2%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Southside Bancshares Inc. is a U.S.-based bank holding company primarily operating in Texas. It offers a full range of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial loans, and wealth management solutions, serving retail customers, small and medium-sized enterprises and local community groups.
ABCL vs SBSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $62.8M |
| Net Profit | $-8.9M | $21.0M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 39.4% |
| Net Margin | -19.9% | 33.4% |
| Revenue YoY | 788.4% | -4.8% |
| Net Profit YoY | 73.9% | -3.7% |
| EPS (diluted) | $-0.03 | $0.70 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $62.8M | ||
| Q3 25 | $9.0M | $43.7M | ||
| Q2 25 | $17.1M | $66.4M | ||
| Q1 25 | $4.2M | $64.1M | ||
| Q4 24 | $5.0M | $66.0M | ||
| Q3 24 | $6.5M | $63.6M | ||
| Q2 24 | $7.3M | $65.2M | ||
| Q1 24 | $10.0M | $63.1M |
| Q4 25 | $-8.9M | $21.0M | ||
| Q3 25 | $-57.1M | $4.9M | ||
| Q2 25 | $-34.7M | $21.8M | ||
| Q1 25 | $-45.6M | $21.5M | ||
| Q4 24 | — | $21.8M | ||
| Q3 24 | $-51.1M | $20.5M | ||
| Q2 24 | $-36.9M | $24.7M | ||
| Q1 24 | $-40.6M | $21.5M |
| Q4 25 | -63.7% | 39.4% | ||
| Q3 25 | -851.8% | 11.7% | ||
| Q2 25 | -290.2% | 40.0% | ||
| Q1 25 | -1479.6% | 40.9% | ||
| Q4 24 | — | 40.1% | ||
| Q3 24 | -1439.4% | 39.2% | ||
| Q2 24 | -1276.2% | 45.9% | ||
| Q1 24 | -551.5% | 41.4% |
| Q4 25 | -19.9% | 33.4% | ||
| Q3 25 | -637.8% | 11.2% | ||
| Q2 25 | -203.3% | 32.8% | ||
| Q1 25 | -1077.2% | 33.6% | ||
| Q4 24 | — | 33.0% | ||
| Q3 24 | -785.4% | 32.3% | ||
| Q2 24 | -504.3% | 37.9% | ||
| Q1 24 | -408.0% | 34.1% |
| Q4 25 | $-0.03 | $0.70 | ||
| Q3 25 | $-0.19 | $0.16 | ||
| Q2 25 | $-0.12 | $0.72 | ||
| Q1 25 | $-0.15 | $0.71 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | $-0.17 | $0.68 | ||
| Q2 24 | $-0.13 | $0.81 | ||
| Q1 24 | $-0.14 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $389.8M |
| Total DebtLower is stronger | — | $300.0M |
| Stockholders' EquityBook value | $966.9M | $847.6M |
| Total Assets | $1.4B | $8.5B |
| Debt / EquityLower = less leverage | — | 0.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $389.8M | ||
| Q3 25 | $83.2M | $466.9M | ||
| Q2 25 | $92.4M | $390.1M | ||
| Q1 25 | $159.3M | $431.0M | ||
| Q4 24 | $156.3M | $426.2M | ||
| Q3 24 | $126.6M | $486.3M | ||
| Q2 24 | $148.3M | $452.0M | ||
| Q1 24 | $123.6M | $469.4M |
| Q4 25 | — | $300.0M | ||
| Q3 25 | — | $299.9M | ||
| Q2 25 | — | $152.4M | ||
| Q1 25 | — | $152.4M | ||
| Q4 24 | — | $152.3M | ||
| Q3 24 | — | $152.3M | ||
| Q2 24 | — | $152.2M | ||
| Q1 24 | — | $154.2M |
| Q4 25 | $966.9M | $847.6M | ||
| Q3 25 | $964.0M | $834.9M | ||
| Q2 25 | $1.0B | $807.2M | ||
| Q1 25 | $1.0B | $816.6M | ||
| Q4 24 | $1.1B | $811.9M | ||
| Q3 24 | $1.1B | $805.3M | ||
| Q2 24 | $1.1B | $801.0M | ||
| Q1 24 | $1.1B | $787.9M |
| Q4 25 | $1.4B | $8.5B | ||
| Q3 25 | $1.4B | $8.4B | ||
| Q2 25 | $1.4B | $8.3B | ||
| Q1 25 | $1.3B | $8.3B | ||
| Q4 24 | $1.4B | $8.5B | ||
| Q3 24 | $1.4B | $8.4B | ||
| Q2 24 | $1.4B | $8.4B | ||
| Q1 24 | $1.5B | $8.4B |
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.19× | ||
| Q1 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $93.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $73.5M |
| FCF MarginFCF / Revenue | -99.4% | 117.0% |
| Capex IntensityCapex / Revenue | 21.9% | 32.4% |
| Cash ConversionOCF / Net Profit | — | 4.47× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $130.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $93.8M | ||
| Q3 25 | $-52.6M | $40.2M | ||
| Q2 25 | $-32.4M | $5.9M | ||
| Q1 25 | $-11.6M | $23.9M | ||
| Q4 24 | $-108.6M | $101.8M | ||
| Q3 24 | $-28.9M | $-11.7M | ||
| Q2 24 | $-30.0M | $16.5M | ||
| Q1 24 | $-41.7M | $58.3M |
| Q4 25 | $-44.6M | $73.5M | ||
| Q3 25 | $-61.5M | $37.4M | ||
| Q2 25 | $-45.8M | $-2.0M | ||
| Q1 25 | $-22.2M | $21.5M | ||
| Q4 24 | $-187.0M | $90.7M | ||
| Q3 24 | $-47.4M | $-14.2M | ||
| Q2 24 | $-50.1M | $15.4M | ||
| Q1 24 | $-65.8M | $55.7M |
| Q4 25 | -99.4% | 117.0% | ||
| Q3 25 | -687.0% | 85.5% | ||
| Q2 25 | -267.9% | -3.0% | ||
| Q1 25 | -524.0% | 33.6% | ||
| Q4 24 | -3702.8% | 137.4% | ||
| Q3 24 | -728.4% | -22.3% | ||
| Q2 24 | -683.8% | 23.6% | ||
| Q1 24 | -661.5% | 88.4% |
| Q4 25 | 21.9% | 32.4% | ||
| Q3 25 | 99.7% | 6.5% | ||
| Q2 25 | 78.2% | 12.0% | ||
| Q1 25 | 251.1% | 3.8% | ||
| Q4 24 | 1552.7% | 16.9% | ||
| Q3 24 | 284.6% | 3.8% | ||
| Q2 24 | 274.6% | 1.7% | ||
| Q1 24 | 242.5% | 4.1% |
| Q4 25 | — | 4.47× | ||
| Q3 25 | — | 8.18× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 4.67× | ||
| Q3 24 | — | -0.57× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | 2.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
